Ensysce Biosciences (ENSC) Net Income towards Common Stockholders (2018 - 2025)
Ensysce Biosciences (ENSC) posted Net Income towards Common Stockholders of -$3.73 million for Q3 2025, compared with $661,769 a year earlier.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Net Income towards Common Stockholders (2018 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Net Income towards Common Stockholders at Ensysce Biosciences was -$10.97 million; for FY2024, it was -$7.99 million.
- In prior years, Ensysce Biosciences' Net Income towards Common Stockholders was -$10.63 million in FY2023, -$25.09 million in FY2022, -$29.89 million in FY2021 and $56,770 in FY2020.
- The Q3 2025 figure stands as the lowest quarterly Net Income towards Common Stockholders since Q4 2022.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was -$1.73 million (Q2 2025), -$1.95 million (Q1 2025) and -$3.56 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Ensysce Biosciences | 1.02 Mn | -10.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3.73 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -1.95 Mn |
| Dec 31, 2024 | -3.56 Mn |
| Sep 30, 2024 | 661,769.00 |
| Jun 30, 2024 | -1.97 Mn |
| Mar 31, 2024 | -3.12 Mn |
| Dec 31, 2023 | -3.50 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.20 Mn |
| Dec 31, 2022 | -5.52 Mn |
| Sep 30, 2022 | -9.90 Mn |
| Jun 30, 2022 | -8.00 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | -10.84 Mn |
| Sep 30, 2021 | -17.16 Mn |
| Jun 30, 2021 | -935,544.00 |
| Mar 31, 2021 | -907,731.00 |
| Dec 31, 2020 | 213,995.00 |
API Access
Ensysce Biosciences Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();